Showing results (251-260 of 258) with videos related to
Sort By:
Pageof 26
You have reached the last page of results.This site can display upto 258 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 15, 2022
Cabozantinib plus Nivolumab Phase I Expansion Study in Patients with Metastatic Urothelial Carcinoma Refractory to Immune Checkpoint Inhibitor TherapyDaniel M Girardi, Scot A Niglio, Amir Mortazavi, et al.The Lancet. Oncology|July 10, 2020
Cabozantinib in patients with platinum-refractory metastatic urothelial carcinoma: an open-label, single-centre, phase 2 trialAndrea B Apolo, Rosa Nadal, Yusuke Tomita, et al.Journal of Extracellular Vesicles|July 2, 2019
High-fidelity detection and sorting of nanoscale vesicles in viral disease and cancerAizea Morales-Kastresana, Thomas A Musich, Joshua A Welsh, et al.Cell Reports Methods|April 27, 2022
MPAPASS software enables stitched multiplex, multidimensional EV repertoire analysis and a standard framework for reporting bead-based assaysJoshua A Welsh, Bryce Killingsworth, Julia Kepley, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 11, 2020
Phase I Study of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced or Metastatic Urothelial Carcinoma and Other Genitourinary TumorsAndrea B Apolo, Rosa Nadal, Daniel M Girardi, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2020
Decitabine and Vorinostat with Chemotherapy in Relapsed Pediatric Acute Lymphoblastic Leukemia: A TACL Pilot StudyMichael J Burke, Rumen Kostadinov, Richard Sposto, et al.Cancer Cell|April 13, 2021
Therapeutic targeting of ATR yields durable regressions in small cell lung cancers with high replication stressAnish Thomas, Nobuyuki Takahashi, Vinodh N Rajapakse, et al.Cell Reports|February 13, 2020
Dynamic Imaging of LDH Inhibition in Tumors Reveals Rapid In Vivo Metabolic Rewiring and Vulnerability to Combination TherapyNobu Oshima, Ryo Ishida, Shun Kishimoto, et al.Pageof 26